Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
Sulphasalazine has been shown to be useful in the management of rheumatoid arthritis. However, its use may be complicated by a skin rash. Eight patients with a rash have undergone desensitisation, the aim of which was to achieve a daily dose of 2 g sulphasalazine. This was successful in five patient...
保存先:
| 出版年: | Ann Rheum Dis |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1986
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001835/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2868699/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.45.2.139 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|